Aldactone Precaution
DO NOT DRIVE, OPERATE MACHINERY, OR DO ANYTHING ELSE THAT COULD BE DANGEROUS until you know how you react to this medicine. Using this medicine alone, with other medicines, or with alcohol may lessen your ability to drive or to perform other potentially dangerous tasks.
DO NOT USE A SALT SUBSTITUTE or potassium supplement without checking with your doctor.
BEFORE YOU BEGIN TAKING ANY NEW MEDICINE, either prescription or over-the-counter, check with your doctor or pharmacist.
FOR WOMEN: THIS MEDICINE IS EXCRETED IN BREAST MILK. DO NOT BREAST-FEED while taking this medicine.
Patients receiving Aldactone (Spironolactone) diuretics therapy must be placed under observation for evidence of Hypomagnesaemia
Patients receiving Aldactone (Spironolactone) diuretics therapy must be placed under observation for evidence of Hyponatremia
Patients receiving Aldactone (Spironolactone) diuretics therapy must be placed under observation for evidence of Hypochloremic Alkalosis
Patients receiving Aldactone (Spironolactone) diuretics therapy must be placed under observation for evidence of Hyperkalemia
Patients receiving Aldactone (Spironolactone) diuretics therapy must be placed under observation for evidence of Drowsiness
Patients receiving Aldactone (Spironolactone) diuretics therapy must be placed under observation for evidence of Restlessness
Patients receiving Aldactone (Spironolactone) diuretics therapy must be placed under observation for evidence of Oliguria
Patients receiving Aldactone (Spironolactone) diuretics therapy must be placed under observation for evidence of Tachycardia
Patients receiving Aldactone (Spironolactone) diuretics therapy must be placed under observation for evidence of Cardiac irregularities
Patients receiving Aldactone (Spironolactone) diuretics therapy must be placed under observation for evidence of Paresthesia
Patients receiving Aldactone (Spironolactone) diuretics therapy must be placed under observation for evidence of Flaccid paralysis of the extremities
Patients receiving Aldactone (Spironolactone) diuretics therapy must be placed under observation for evidence of Bradycardia
Patients receiving Aldactone (Spironolactone) diuretics therapy must be placed under observation for evidence of Shock
Patients receiving Aldactone (Spironolactone) diuretics therapy must be placed under observation for evidence of Low serum sodium level
Patients receiving Aldactone (Spironolactone) diuretics therapy must be placed under observation for evidence of Mild acidosis |